Suppr超能文献

人类CD8+ T细胞释放与细胞毒性囊泡共定位的细胞外陷阱,这些陷阱与人类利什曼病的病变进展和严重程度相关。

Human CD8+ T Cells Release Extracellular Traps Co-Localized With Cytotoxic Vesicles That Are Associated With Lesion Progression and Severity in Human Leishmaniasis.

作者信息

Koh Carolina Cattoni, Wardini Amanda B, Vieira Millene, Passos Livia S A, Martinelli Patrícia Massara, Neves Eula Graciele A, Antonelli Lis Riberido do Vale, Barbosa Daniela Faria, Velikkakam Teresiama, Gutseit Eduardo, Menezes Gustavo B, Giunchetti Rodolfo Cordeiro, Machado Paulo Roberto Lima, Carvalho Edgar M, Gollob Kenneth J, Dutra Walderez Ornelas

机构信息

Laboratório de Biologia das Interações Celulares, Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Laboratório Profa. Conceição Machado, Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

出版信息

Front Immunol. 2020 Oct 8;11:594581. doi: 10.3389/fimmu.2020.594581. eCollection 2020.

Abstract

Cell death plays a fundamental role in mounting protective and pathogenic immunity. Etosis is a cell death mechanism defined by the release of extracellular traps (ETs), which can foster inflammation and exert microbicidal activity. While etosis is often associated with innate cells, recent studies showed that B cells and CD4+ T cells can release ETs. Here we investigate whether CD8+ T cells can also release ETs, which might be related to cytotoxicity and tissue pathology. To these ends, we first employed an in vitro system stimulating human CD8+ T cells isolated from healthy volunteers with anti-CD3/anti-CD28. Using time-frame video, confocal and electron microscopy, we demonstrate that human CD8+ T cells release ETs upon stimulation (herein LETs - lymphocyte extracellular traps), which display unique morphology and functional characteristics. CD8+ T cell-derived LETs form long strands that co-localize with CD107a, a marker of vesicles containing cytotoxic granules. In addition, these structures connect the LET-releasing cell to other neighboring cells, often resulting in cell death. After demonstrating the release of LETs by human CD8+ T cells in vitro, we went on to study the occurrence of CD8-derived LETs in a human disease setting. Thus, we evaluated the occurrence of CD8-derived LETs in lesions from patients with human tegumentary leishmaniasis, where CD8+ T cells play a key role in mediating pathology. In addition, we evaluated the association of these structures with the intensity of the inflammatory infiltrate in early and late cutaneous, as well as in mucosal leishmaniasis lesions. We demonstrated that progression and severity of debilitating and mutilating forms of human tegumentary leishmaniasis are associated with the frequency of CD8+ T cells in etosis, as well as the occurrence of CD8-derived LETs carrying CD107a+ vesicles in the lesions. We propose that CD8+ T cell derived LETs may serve as a tool for delivering cytotoxic vesicles to distant target cells, providing insights into mechanisms of CD8+ T cell mediated pathology.

摘要

细胞死亡在启动保护性和致病性免疫中发挥着基本作用。细胞外诱捕作用(Etosis)是一种由细胞外陷阱(ETs)释放所定义的细胞死亡机制,ETs可促进炎症并发挥杀菌活性。虽然细胞外诱捕作用通常与固有细胞相关,但最近的研究表明B细胞和CD4+ T细胞也能释放ETs。在此,我们研究CD8+ T细胞是否也能释放ETs,这可能与细胞毒性和组织病理学有关。为此,我们首先采用体外系统,用抗CD3/抗CD28刺激从健康志愿者中分离出的人CD8+ T细胞。利用时间框架视频、共聚焦显微镜和电子显微镜,我们证明人CD8+ T细胞在受到刺激后会释放ETs(在此称为淋巴细胞细胞外陷阱,即LETs),其呈现出独特的形态和功能特征。CD8+ T细胞衍生的LETs形成长链,与CD107a共定位,CD107a是含有细胞毒性颗粒的囊泡的标志物。此外,这些结构将释放LET的细胞与其他相邻细胞连接起来,常常导致细胞死亡。在体外证明人CD8+ T细胞可释放LETs后,我们接着研究在人类疾病背景下CD8衍生的LETs的发生情况。因此,我们评估了人类皮肤利什曼病患者病变中CD8衍生的LETs的发生情况,其中CD8+ T细胞在介导病理过程中起关键作用。此外,我们评估了这些结构与早期和晚期皮肤以及黏膜利什曼病病变中炎症浸润强度的关联。我们证明,使人衰弱和致残的人类皮肤利什曼病的进展和严重程度与处于细胞外诱捕状态的CD8+ T细胞的频率以及病变中携带CD107a+囊泡的CD8衍生的LETs的发生情况相关。我们提出,CD8+ T细胞衍生的LETs可能作为一种将细胞毒性囊泡递送至远处靶细胞的工具,为深入了解CD8+ T细胞介导的病理机制提供了思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b7f/7578246/6cb0206af7b5/fimmu-11-594581-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验